| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |